Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $1.33 0.1600 +13.68%
CBMG $27.11 2.3400 +9.45%
NYMX $2.72 0.1500 +5.84%
GALE $1.70 0.0900 +5.59%
MEIP $1.65 0.0800 +5.10%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.10 -0.0700 -41.18%
IMMU $2.11 -0.4400 -17.25%
PGNX $8.43 -0.9900 -10.51%
IMDZ $21.04 -2.0100 -8.72%
MDVN $95.74 -8.7700 -8.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Nanotechnology and the Fight Against Cancer

(The Guardian [UK]/Nanochannels) Jan 31, 2012 - Leading cancer clinician Prof Mario Airoldi, director of medical oncology at the San Giovanni Battista hospital in Turin thinks that nanomedicine is set to make the groundbreaking switch from a curative to a preventative approach.
read article 

FDA Is Accused of Spying on Its Employees Over Complaints Made to Congress

(Bloomberg) Jan 30, 2012 - U.S. Food and Drug Administration employees accused the agency of spying on staff members who told lawmakers it was improperly approving medical devices used to screen for cancer.
read article 

Gene Linked to Pancreatic Cancer Growth, U-M Study Finds

(U-M CCC) Jan 31, 2012 - A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers.
read press release 

Diabetes Drugs Tied to Pancreatic Cancer Risk

(Reuters) Jan 31, 2012 - A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.
read article 

Cancer Patients Pain Can Be Helped By Psychosocial Interventions, Say Moffitt Cancer Center Researchers

(Moffit Cancer Center) Jan 30, 2012 - Researchers at Moffitt Cancer Center, who teamed with colleagues at five universities around the United States, analyzed past studies of cancer-related pain reduction and found that psychosocial interventions can have a beneficial effect on cancer patients' pain severity.
read press release 

Inherited Risk Factors for Childhood Leukemia are More Common in Hispanic Patients

(St. Jude) Jan 30, 2012 - Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children’s Research Hospital scientists has pinpointed genetic factors behind the grim statistics.
read press release 

Four-Week Vaccination Regimen Knocks Out Early Breast Cancer Tumors, Penn Researchers Report

(Abramson Cancer Center) Jan 30, 2012 - Researchers at the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient’s own cells triggers a complete tumor eradication in nearly 20 percent of women with ductal carcinoma in situ (DCIS), an early breast cancer.
read press release 

Pricey Surgery Robots Lack Clear Benefits: Study

(Reuters) Jan 30, 2012 - As robots march into operating rooms across the nation, some doctors are getting worried that patients might not be better off with the costly machines.
read article 

F.D.A. Approves Drug for an Advanced Skin Cancer

(NYT/Prescriptions blog) Jan 30, 2012 - The first drug for an advanced form of the most common type of skin cancer won approval from the Food and Drug Administration on Monday.
read article 

Cancer Survivor Chooses Career in Oncology

(Omaha World-Herald) Jan 31, 2012 - One day after that call from her dad, she would be diagnosed with Hodgkin's lymphoma, a cancer of the immune system that is relatively uncommon but also typically highly curable.
read article 

US FDA Approves Roche and Curis Skin Cancer Drug

(Fox Business/Dow Jones Newswires) Jan 30, 2012 - The U.S. Food and Drug Administration approved a drug developed by Roche Holding AG and Curis Inc. to treat advanced cases of basal cell skin cancer, the most common type of skin cancer.
read article 

Cell Therapeutics Pulls Cancer Drug After CEO Boasted About Approval Chances

(The Street) Jan 30, 2012 - Cell Therapeutics withdrew its U.S. approval application for the experimental lymphoma pixantrone due to unresolved and undisclosed "communications" with the U.S. Food and Drug Administration, the company said.
read article 

Big Pharma Donates Drugs for Neglected Diseases

(Reuters) Jan 30, 2012 - The world's major pharmaceutical companies joined forces with governments and leading global health organizations Monday to donate drugs and scientific know-how to help control or wipe out 10 neglected tropical diseases by 2020.
read article 

Medicare Seen as Battleground Issue in Congressional Races

(New York Times) Jan 27, 2012 - A Republican plan to remake Medicare, set forth in a budget blueprint devised by Representative Paul D. Ryan, has largely faded from public view.
read article 

FDA Approves Amylin's Bydureon Diabetes Drug After Delays

(Morningstar/Dow Jones Newswires) Jan 27, 2012 - The U.S. Food and Drug Administration approved Amylin Pharmaceuticals Inc.'s diabetes drug Bydureon after a prolonged regulatory process in which the agency required extra testing to alleviate safety concerns.
read article 

Researchers Find Cancer in Ancient Egyptian Mummy

(USA Today/Associated Press) Jan 28, 2012 - A professor from American University in Cairo says discovery of prostate cancer in a 2,200-year-old mummy indicates the disease was caused by genetics, not environment.
read article 

Palm Beach County Cancer Center Hopes to Bring Proton Therapy to Area

(Palm Beach Post) Jan 29, 2012 - Tired of sending patients to Jacksonville for the latest cancer treatment, a group of Palm Beach County doctors hopes to spend $30 million to build South Florida's first proton therapy center.
read article 

Radiologist Adds to Debate on Breast Cancer Screenings

(Salt Lake Tribune) Jan 28, 2012 - Advice to local doctors from the chief radiologist at one of the nation’s leading medical schools: Mammography remains the most effective and affordable tool for detecting breast cancer and, for women with average risk of developing the disease, annual screening should begin at age 40.
read article 

UNMC Aims to Compete with Mayo

(Omaha World-Herald) Jan 28, 2012 - The goal behind the $370 million cancer center proposed for the University of Nebraska Medical Center campus is not to lure patients from other local providers. It's to "provide an option so people don't have to leave the state for the most significant care," said Glenn Fosdick, CEO of the Nebraska Medical Center, UNMC's hospital partner.
read article 

N.J. Oncology Network Promises Benefits for Patients

( Star-Ledger) Jan 29, 2012 - A statewide group of 76 oncologists have consolidated their practices into a new oncology network they said will lower costs and pool resources for more than one-third of New Jersey’s cancer patients.
read article 

How Doctors Do Harm

(CNN Health) Jan 30, 2012 - CNN conditions expert Dr. Otis Webb Brawley is the chief medical officer of the American Cancer Society, a world-renowned cancer expert and a practicing oncologist. His book, "How We Do Harm: A Doctor Breaks Ranks About Being Sick in America," will be released January 31.
read article 

Allos Therapeutics Seeks Review of European Agency's Negative Opinion on Cancer Drug

(Denver Business Journal) Jan 30, 2012 - Allos Therapeutics Inc. said Monday that it has asked the European Medicines Agency (EMA) to re-examine a negative opinion against its lymphoma drug Folotyn.
read article 

Teva's Cephalon Recalls One Lot of Injectable Leukemia Drug Treanda

(Philadelphia Inquirer/PhillyPharma blog) Jan 27, 2012 - Teva Pharmaceuticals' subsidiary Cephalon said Friday that it had issued a recall in November for one lot of the injectable leukemia drug Treanda because glass fragments were found in one vial of the drug.
read article 

Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN(R) and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma

(MarketWatch) Jan 30, 2012 - Allos Therapeutics, today reported interim results from the Company's ongoing Phase 1 combination study of FOLOTYN(R) (pralatrexate injection) and bexarotene in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL).
read article 

Barrett’s Patients Who Smoke Twice as Likely to Develop Oesophageal Cancer

(Queen’s University Belfast) Jan 30, 2012 - Smoking doubles the risk of developing oesophageal cancer in people with Barrett’s Oesophagus, according to scientists at Queen’s University Belfast and the Northern Ireland Cancer Registry.
read press release